Medigus wins FDA clearance for the next generation of its minimally invasive MUSE system for treating acid reflux through the mouth.
Israel-based Medigus (TLV:MDGS) won FDA clearance for the next generation of its MUSE technology, a minimally invasive technology for performing surgeries to treat acid reflux disease.
News Well, Regulatory/Clearance, 510(k), Endovascular, Food & Drug Administration (FDA), Minimally Invasive Surgery, Surgical
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1gyb3ea
Cap comentari:
Publica un comentari a l'entrada